Stem cell therapy shows promise in small clinical trial for rare lung disease

Canadian researchers have published promising results of the first clinical trial in the world of a genetically-enhanced stem cell therapy for pulmonary arterial hypertension (PAH).

[Read the full article here]

Comments are closed.